Pharmacodynamics and pharmacokinetics of extended-release metformin in patients with type 2 diabetes and chronic kidney disease stage 3B - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Diabetes, Obesity and Metabolism Année : 2022

Pharmacodynamics and pharmacokinetics of extended-release metformin in patients with type 2 diabetes and chronic kidney disease stage 3B

(1, 2) , (1, 3) , (1, 2) , (1) , (1)
1
2
3

Dates et versions

hal-03547671 , version 1 (28-01-2022)

Identifiants

Citer

Jean-Daniel Lalau, Youssef Bennis, Abdallah Al-Salameh, Anne-Sophie Hurtel-Lemaire, Salha Fendri. Pharmacodynamics and pharmacokinetics of extended-release metformin in patients with type 2 diabetes and chronic kidney disease stage 3B. Diabetes, Obesity and Metabolism, 2022, 24 (1), pp.166-170. ⟨10.1111/dom.14554⟩. ⟨hal-03547671⟩
7 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More